Mycamine inhibits the synthesis of 1,3-B-D-glucan, an essential component of the fungal cell wall.
Treatment must be initiated by a specialist and the decision to use Mycamine should take into account a potential risk of developing liver tumours. Liver function must be carefully monitored throughout treatment.
- Invasive candidiasis in adults and children.
- Oesophageal candidiasis in patients aged >16 years where iv therapy is appropriate.
- Prophylaxis of candida infection in adults and children undergoing allogeneic haematopoietic stem cell transplantation or patients expected to have neutropenia for >10 days.
Further information: Astellas